Come up with a name for your new list and we'll add to it:
LigoCyte Pharmaceuticals raised a round of funding on December 11, 2009. Investors include
Qualifying Therapeutic Discovery Project.
Ligocyte focuses on cellular immunology and new approaches to fight dangerous pathogens. The company's lead programs include vaccines against norovirus, anthrax and influenza.…